PTPN22 and neoplasm: Earlier, HABP1 has been already mentioned to act as a receptor for the tumor homing, anti-cancerous, cyclic nonapeptide, Lyp-1 (CGNKRTRGC), which specifically recognizes an epitope in tumor-associated macrophage myeloid cells and tumor lymphatics [148].